Lowering LDL in patients with heart disease: how aggressive should you be?
Pearson
T A
TA
Department of Community and Preventive Medicine, University of Rochester Medical Center, New York, USA.
Pashkow
F J
FJ
D000924:Anticholesteremic Agents / Q000008:administration & dosage*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000517:prevention & control; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006951:Hyperlipoproteinemias / Q000188:drug therapy*; D008077:Lipoproteins, LDL / Q000032:analysis / Q000187:drug effects*; D008297:Male; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D008077:Lipoproteins, LDL